Lidocaine for Neuropathic Cancer Pain (LiCPain): A Pilot Randomized Controlled Trial

This pilot demonstrates that a phase III clinical trial of extended continuous subcutaneous infusion of lidocaine for neuropathic cancer pain is feasible and provides important insights into modifications required to improve recruitment. Serum levels and relative safety suggest higher lidocaine doses could be cautiously evaluated. As the only prospective trial we are aware of to date, this trial informs clinical use of subcutaneous lidocaine infused over days.

Authors

Institutions

Publication Details

Journal
Journal of Pain and Symptom Management
Published
2025-06-02
DOI
https://doi.org/10.1016/j.jpainsymman.2025.05.015
Citations
2
Primary Topic
Pain Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
2.33
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lidocaine for Neuropathic Cancer Pain (LiCPain): A Pilot Randomized Controlled Trial

Nikki McCaffrey, David C. Currow, Jane Phillips, Marian Kow et al.
2 citations
Journal of Pain and Symptom Management
Pain Mechanisms and Treatments
2.33
article

Lidocaine for Neuropathic Cancer Pain (LiCPain): A Pilot Randomized Controlled Trial

Nikki McCaffrey, David C. Currow, Jane Phillips, Marian Kow, Kat Urban, Jessica Lee, Dipti Mittal, Bill Noble, Anthony Linton, Belinda Butcher, Andrew J. McLachlan, Priyanka Vandersman, Belinda Fazekas, Caitlin Sheehan, Megan Ritchie, Christine Sanderson, Meera Agar, Richard Chye, Davinia S. E. Seah, Ghauri Aggarwal, Angela Rao, Rajesh Aggarwal, Chadi Ayoub, Melanie Lovell, Rachel George, Eugenia Hutton
article en
2 citations

Abstract

This pilot demonstrates that a phase III clinical trial of extended continuous subcutaneous infusion of lidocaine for neuropathic cancer pain is feasible and provides important insights into modifications required to improve recruitment. Serum levels and relative safety suggest higher lidocaine doses could be cautiously evaluated. As the only prospective trial we are aware of to date, this trial informs clinical use of subcutaneous lidocaine infused over days.

Journal of Pain and Symptom ManagementVol. 70(3)
University of Technology Sydney (AU), The University of Sydney (AU), University of Tasmania (AU), Deakin University (AU), Flinders University (AU), Concord Repatriation General Hospital (AU), Flinders Medical Centre (AU), UNSW Sydney (AU), St Vincent's Hospital Sydney (AU), Government of the Northern Territory (AU), Northern Sydney Local Health District (AU), Mayo Clinic in Arizona (US), Calvary Hospital (AU), Sydney Local Health District (AU)
Good health and well-being
Openalex Percentile: Top 12%
Pain Mechanisms and Treatments
2.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.